Researchers sought to examine the safety of aspirin as a primary prevention method for atherosclerotic cardiovascular events in high-risk patients. The use of aspirin as a primary prevention for ...

Low-dose aspirin therapy can reduce severe adverse vascular events. Investigators in the Japanese Primary Prevention Project sought to determine whether low-dose aspirin therapy can reduce the ...

A preliminary study found that adults with type 2 diabetes and a moderate or high risk of cardiovascular disease were less likely to experience a serious cardiovascular event when taking low-dose ...

People with type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...

People with Type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...

Patients taking long-term, low-dose aspirin for primary or secondary prevention may be placing themselves at risk for cardiovascular events if they discontinue treatment for reasons not related to ...

Recommendations on the use of low-dose aspirin for the primary prevention of cardiovascular disease in women are, in fact, based on data derived mainly from men. Recent results from the Women's Health ...

Aspirin, in woman’s hand, elderly “An aspirin a day keeps the doctor away?” Daily aspirin use for primary prevention of CVD has been recommended against by the USPSTF. The most recent recommendations ...

A recent analysis from the large ADAPTABLE trial published in JAMA Cardiology showed that enteric coating on aspirin does not change effectiveness or safety for patients with cardiovascular disease.